DE60034957D1 - Zusammensetungen und verfahren zur modulation von apoptose in cellen, die proteine der bc1-2-familie exprimieren - Google Patents

Zusammensetungen und verfahren zur modulation von apoptose in cellen, die proteine der bc1-2-familie exprimieren

Info

Publication number
DE60034957D1
DE60034957D1 DE60034957T DE60034957T DE60034957D1 DE 60034957 D1 DE60034957 D1 DE 60034957D1 DE 60034957 T DE60034957 T DE 60034957T DE 60034957 T DE60034957 T DE 60034957T DE 60034957 D1 DE60034957 D1 DE 60034957D1
Authority
DE
Germany
Prior art keywords
compositions
agents
methods
cells expressing
family proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60034957T
Other languages
English (en)
Other versions
DE60034957T2 (de
Inventor
David M Hockenbery
Julian A Simon
Shie-Pon Tzung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fred Hutchinson Cancer Center
Original Assignee
Fred Hutchinson Cancer Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fred Hutchinson Cancer Research Center filed Critical Fred Hutchinson Cancer Research Center
Application granted granted Critical
Publication of DE60034957D1 publication Critical patent/DE60034957D1/de
Publication of DE60034957T2 publication Critical patent/DE60034957T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
DE60034957T 1999-08-20 2000-08-18 Zusammensetungen und verfahren zur modulation von apoptose in cellen, die proteine der bc1-2-familie exprimieren Expired - Lifetime DE60034957T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14996899P 1999-08-20 1999-08-20
US149968P 1999-08-20
PCT/US2000/022891 WO2001014365A1 (en) 1999-08-20 2000-08-18 COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING bcl-2 FAMILY MEMBER PROTEINS

Publications (2)

Publication Number Publication Date
DE60034957D1 true DE60034957D1 (de) 2007-07-05
DE60034957T2 DE60034957T2 (de) 2008-01-31

Family

ID=22532570

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60034957T Expired - Lifetime DE60034957T2 (de) 1999-08-20 2000-08-18 Zusammensetungen und verfahren zur modulation von apoptose in cellen, die proteine der bc1-2-familie exprimieren

Country Status (9)

Country Link
US (1) US20090203770A1 (de)
EP (1) EP1218368B1 (de)
JP (1) JP2003507474A (de)
AT (1) ATE362925T1 (de)
AU (1) AU781272B2 (de)
CA (1) CA2382465C (de)
DE (1) DE60034957T2 (de)
ES (1) ES2287029T3 (de)
WO (1) WO2001014365A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101917B2 (en) 2003-04-14 2006-09-05 Hoffmann-La Roche Inc. Mitochrondrial permeability transition pore affinity labels and modulators
CA2738983C (en) * 2008-10-10 2018-05-15 Dana Farber Cancer Institute Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides
DK3178321T3 (da) 2009-10-07 2019-08-26 Dow Agrosciences Llc Synergistiske fungicide blandninger af epoxiconazol til bekæmpelse af svamp i korn
WO2012070015A1 (en) * 2010-11-24 2012-05-31 Stemergie Biotechnology Sa Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases
BR112015015351B8 (pt) 2012-12-28 2022-08-23 Dow Agrosciences Llc Mistura fungicida sinérgica, composição fungicida, e método para tratamento de uma planta
AU2013370555A1 (en) 2012-12-31 2015-07-02 Dow Agrosciences Llc Macrocyclic picolinamides as fungicides
CN106028814A (zh) 2013-12-26 2016-10-12 美国陶氏益农公司 大环吡啶酰胺作为杀真菌剂的用途
EP3086642A4 (de) 2013-12-26 2017-09-27 Dow Agrosciences LLC Verwendung makrocyclischer picolinamide als fungizide
BR112016025397A2 (pt) * 2014-05-06 2017-08-15 Dow Agrosciences Llc picolinamidas macrocíclicas como fungicidas
EP3166935A4 (de) 2014-07-08 2017-11-22 Dow AgroSciences LLC Makrocyclische picolinamide als fungizide
BR112017000169A2 (pt) 2014-07-08 2017-10-31 Dow Agrosciences Llc picolinamidas macrocíclicas como fungicidas
JP6684810B2 (ja) 2014-12-30 2020-04-22 ダウ アグロサイエンシィズ エルエルシー 殺真菌剤としてのピコリンアミド化合物の使用
AU2015374459A1 (en) 2014-12-30 2017-06-29 Dow Agrosciences Llc Picolinamide compounds with fungicidal activity
BR112017013608B8 (pt) 2014-12-30 2022-08-23 Dow Agrosciences Llc Picolinamidas como fungicidas
ES2927889T3 (es) 2014-12-30 2022-11-11 Corteva Agriscience Llc Composiciones fungicidas
KR20170099928A (ko) 2014-12-30 2017-09-01 다우 아그로사이언시즈 엘엘씨 살진균 활성을 갖는 피콜린아미드
NZ732657A (en) 2014-12-30 2019-01-25 Dow Agrosciences Llc Picolinamides with fungicidal activity and other related compounds
WO2018044996A1 (en) 2016-08-30 2018-03-08 Dow Agrosciences Llc Picolinamides as fungicides
WO2018045012A1 (en) 2016-08-30 2018-03-08 Dow Agrosciences Llc Pyrido-1,3-oxazine-2,4-dione compounds with fungicidal activity
WO2018045006A1 (en) 2016-08-30 2018-03-08 Dow Agrosciences Llc Picolinamide n-oxide compounds with fungicidal activity
WO2018044987A1 (en) 2016-08-30 2018-03-08 Dow Agrosciences Llc Thiopicolinamide compounds with fungicidal activity
BR102018000183B1 (pt) 2017-01-05 2023-04-25 Dow Agrosciences Llc Picolinamidas, composição para controle de um patógeno fúngico, e método para controle e prevenção de um ataque por fungos em uma planta
TWI774761B (zh) 2017-05-02 2022-08-21 美商科迪華農業科技有限責任公司 用於穀物中的真菌防治之協同性混合物
WO2018204438A1 (en) 2017-05-02 2018-11-08 Dow Agrosciences Llc Use of an acyclic picolinamide compound as a fungicide for fungal diseases on turfgrasses
TW201842851A (zh) 2017-05-02 2018-12-16 美商陶氏農業科學公司 用於穀類中的真菌防治之協同性混合物
BR102019004480B1 (pt) 2018-03-08 2023-03-28 Dow Agrosciences Llc Picolinamidas como fungicidas
KR20210076072A (ko) 2018-10-15 2021-06-23 코르테바 애그리사이언스 엘엘씨 옥시피콜린아미드의 합성 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05155877A (ja) * 1991-08-15 1993-06-22 Kaiyo Bio Technol Kenkyusho:Kk 新規物質ウラウチマイシンａ、ウラウチマイシンｂおよ びそれらの製造法
US5539094A (en) * 1993-11-12 1996-07-23 La Jolla Cancer Research Foundation DNA encoding Bcl-2-associated proteins
JPH07196489A (ja) * 1993-12-28 1995-08-01 Kobe Steel Ltd ヒト腫瘍細胞に対する選択的細胞障害剤
BR9812216A (pt) * 1997-09-15 2000-07-18 Eastman Chem Co Diéster macrocìclico, processo de preparação de um diéster macrocìclico, polìmero, e, monoéster
DE69933198T2 (de) * 1998-02-06 2007-09-13 Meiji Seika Kaisha Ltd. Neue fungizide verbindungen und verfahren zu ihrer herstellung
EP1196388A2 (de) * 1999-07-20 2002-04-17 Dow AgroSciences LLC Fungizide heterocyclische aromatische amide und deren zusammensetzungen, verfahren zu deren anwendung und herstellung
US7241804B1 (en) * 2000-08-18 2007-07-10 Fred Hutchinson Cancer Research Center Compositions and methods for modulating apoptosis in cells over-expressing Bcl-2 family member proteins

Also Published As

Publication number Publication date
DE60034957T2 (de) 2008-01-31
ES2287029T3 (es) 2007-12-16
US20090203770A1 (en) 2009-08-13
CA2382465A1 (en) 2001-03-01
ATE362925T1 (de) 2007-06-15
AU781272B2 (en) 2005-05-12
EP1218368B1 (de) 2007-05-23
AU7063400A (en) 2001-03-19
EP1218368A1 (de) 2002-07-03
CA2382465C (en) 2010-05-18
JP2003507474A (ja) 2003-02-25
WO2001014365A1 (en) 2001-03-01
EP1218368A4 (de) 2003-04-16

Similar Documents

Publication Publication Date Title
DE60034957D1 (de) Zusammensetungen und verfahren zur modulation von apoptose in cellen, die proteine der bc1-2-familie exprimieren
ATE377081T1 (de) Material und verfahren die hybridvaskularendothelwachstumfaktoren dns und proteine enthalten und screeningverfahren für modulatoren
DE60016227D1 (de) Globularer aufbau vom amyloid-beta- protein und deren verwendungen
ATE409181T1 (de) Proteomimetische verbindungen und verfahren
PT1044197E (pt) Carboxamidas de piridilalcano, -alceno e -alcino substituidas por piperidinilo como agentes citostaticos e imunossupressores
TR199802421T2 (xx) Doku yenilenmesini d�zenleyen maddeler.
DE69918296D1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
WO2002086122A3 (en) Protein-protein interactions in adipocytes
WO2002024692A8 (en) 1-azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
ATE417605T1 (de) Proteine die cross-beta-struktur enthaltendes amyloid binden, sowie verfahren zur modulation der cross-beta-struktur, ihrer bildung und der damit zusammenhängenden toxizität
WO2003046176A3 (en) Protein-protein interactions in human immunodeficiency virus
WO2000042031A3 (en) Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
PT1228097E (pt) Actividade antimicrobiana do primeiro grupo cationico da lactoferrina humana
EP2083018A3 (de) Zusammensetzungen und Verfahren mit Bezug zu STOP-1
WO2003035688A3 (en) Targeted thrombosis by tissue factor polypeptides
WO2000013712A3 (en) Methods and compositions for the prevention or treatment of cancer
DE60024997D1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
WO2001007479A3 (en) Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
DE60319135D1 (de) Peptide, die die heparinbindungsdomäne von vegf und vegfr-2 binden
WO2002053726A3 (en) Protein-protein interactions in adipocyte cells
WO2002090544A3 (en) Protein-protein interactions in adipocyte cells (3)
DK1453520T3 (da) Sammensætning af östrogen og andre hormoner med askorbinsyre, lysin, prolin og andre stoffer
WO2004078130A3 (en) Posh interacting proteins and related methods
ATE368476T1 (de) Neuropeptid-y1-rezeptor-bindende verbindungen zur behandlung und diagnose von krebserkrankungen
WO2003045990A3 (en) Protein-protein interactions involving transforming growth factor beta signalling

Legal Events

Date Code Title Description
8364 No opposition during term of opposition